Home › Compare › COPHF vs FCPT

COPHF vs FCPT: Dividend Comparison 2026

COPHF yields 1709.40% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 COPHF wins by $2322151466.31M in total portfolio value
10 years
COPHF
COPHF
● Live price
1709.40%
Share price
$0.12
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2322151466.36M
Annual income
$2,082,500,711,449,475.00
Full COPHF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — COPHF vs FCPT

📍 COPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCOPHFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, COPHF + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
COPHF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

COPHF
Annual income on $10K today (after 15% tax)
$145,299.15/yr
After 10yr DRIP, annual income (after tax)
$1,770,125,604,732,053.80/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, COPHF beats the other by $1,770,125,604,727,144.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of COPHF + FCPT for your $10,000?

COPHF: 50%FCPT: 50%
100% FCPT50/50100% COPHF
Portfolio after 10yr
$1161075733.21M
Annual income
$1,041,250,355,727,625.10/yr
Blended yield
89.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

COPHF
No analyst data
Altman Z
-15.1
Piotroski
4/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

COPHF buys
0
FCPT buys
0
No recent congressional trades found for COPHF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCOPHFFCPT
Forward yield1709.40% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$2322151466.36M ✓$49.1K
Annual income after 10y$2,082,500,711,449,475.00 ✓$5,775.28
Total dividends collected$2304918550.89M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: COPHF vs FCPT ($10,000, DRIP)

YearCOPHF PortfolioCOPHF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$181,640$170,940.17$11,401$700.92+$170.2K → COPHF
2$3,096,187$2,901,831.95$13,064$864.84+$3.08M → COPHF
3$49,540,776$46,227,856.03$15,051$1,072.48+$49.53M → COPHF
4$744,291,200$691,282,569.33$17,442$1,337.22+$744.27M → COPHF
5$10,502,651,287$9,706,259,702.90$20,340$1,677.08+$10502.63M → COPHF
6$139,242,028,591$128,004,191,713.95$23,880$2,116.57+$139242.00M → COPHF
7$1,735,020,474,520$1,586,031,503,927.80$28,241$2,689.36+$1735020.45M → COPHF
8$20,326,276,226,909$18,469,804,319,173.38$33,660$3,442.07+$20326276.19M → COPHF
9$223,972,668,143,395$202,223,552,580,602.00$40,456$4,439.95+$223972668.10M → COPHF
10$2,322,151,466,362,908$2,082,500,711,449,475.00$49,063$5,775.28+$2322151466.31M → COPHF

COPHF vs FCPT: Complete Analysis 2026

COPHF — Stock

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Full COPHF Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this COPHF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

COPHF vs SCHDCOPHF vs JEPICOPHF vs OCOPHF vs KOCOPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.